Literature DB >> 7339263

Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens.

A E Wakeling, B J Furr, A T Glen, L R Hughes.   

Abstract

Mesh:

Substances:

Year:  1981        PMID: 7339263     DOI: 10.1016/0022-4731(81)90297-1

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  11 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

2.  Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors.

Authors:  Berkley E Gryder; Michelle J Akbashev; Michael K Rood; Eric D Raftery; Warren M Meyers; Paulette Dillard; Shafiq Khan; Adegboyega K Oyelere
Journal:  ACS Chem Biol       Date:  2013-09-20       Impact factor: 5.100

3.  In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.

Authors:  Jiyun Chen; Dong Jin Hwang; Kiwon Chung; Casey E Bohl; Scott J Fisher; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2005-09-15       Impact factor: 4.736

Review 4.  Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.

Authors:  Wenqing Gao; Juhyun Kim; James T Dalton
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors.

Authors:  H J Grill; B Manz; W Elger; K Pollow
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

Review 6.  Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors:  L B Barradell; D Faulds
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

7.  Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.

Authors:  M R Schneider; R W Hartmann; F Sinowatz; W Amselgruber
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP.

Authors:  D A Wolf; P Schulz; F Fittler
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

9.  OECD validation of the Hershberger assay in Japan: phase 2 dose response of methyltestosterone, vinclozolin, and p,p'-DDE.

Authors:  Kanji Yamasaki; Masakuni Sawaki; Ryo Ohta; Hirokazu Okuda; Seiichi Katayama; Tomoya Yamada; Takafumi Ohta; Tadashi Kosaka; William Owens
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

10.  Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone.

Authors:  D A Wolf; F Kohlhuber; P Schulz; F Fittler; D Eick
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.